Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non–Small Cell Lung Cancer Treated With Erlotinib

Kahraman D, Holstein A, Scheffler, M, Zander T, Nogova L, Lammertsma, A, Boellaard R, Neumaier B, Dietlein M, Wolf J, Kobe, C

Journal: Clinical Nuclear Medicine. Vol 37, No 11, doi: 10.1097/RLU.0b013e3182639747
Veröffentlichung: 2012